US Stock MarketDetailed Quotes

Impact BioMedical (IBO)

Watchlist
  • 0.4515
  • -0.0234-4.93%
Close Jan 16 15:34 ET
  • 0.4502
  • -0.0013-0.29%
Post 20:01 ET
47.24MMarket Cap-0.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Impact BioMedical (IBO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
18K
7K
0
0
0
0
0
0
0
0
Operating revenue
--18K
--7K
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
1K
11K
0
0
Gross profit
17K
-4K
0
0
Operating expense
-14.37%965K
83.55%1.15M
31.00%1.01M
-15.67%3.4M
-23.18%875K
4.55%1.13M
-37.90%626K
-3.99%771K
16.62%4.03M
10.37%1.14M
Selling and administrative expenses
-28.23%516K
215.89%676K
66.89%509K
65.67%1.83M
361.72%591K
65.29%719K
-53.28%214K
-9.50%305K
5.44%1.1M
-37.25%128K
-Selling and marketing expense
-99.57%2K
-94.44%1K
137.50%19K
873.85%633K
595.24%146K
2,611.76%461K
80.00%18K
-52.94%8K
-80.00%65K
-46.15%21K
-General and administrative expense
99.22%514K
244.39%675K
64.98%490K
15.11%1.2M
315.89%445K
-38.28%258K
-56.25%196K
-7.19%297K
-0.76%1.04M
-47.55%107K
Research and development costs
-36.59%52K
-38.02%75K
-43.72%103K
-83.50%278K
-117.14%-108K
-77.03%82K
-54.51%121K
2.23%183K
37.44%1.69M
20.69%630K
Depreciation amortization depletion
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
-Depreciation and amortization
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
Other operating expenses
142.22%109K
816.67%110K
3,733.33%115K
43.70%171K
11.88%113K
650.00%45K
200.00%12K
-57.14%3K
75.00%119K
260.71%101K
Operating profit
15.88%-948K
-84.19%-1.15M
-31.00%-1.01M
15.67%-3.4M
23.18%-875K
-4.55%-1.13M
37.90%-626K
3.99%-771K
-18.33%-4.03M
-10.37%-1.14M
Net non-operating interest income expense
14.24%-259K
0.39%-257K
-18.06%-268K
-144.08%-1.05M
-118.85%-267K
-205.05%-302K
-128.32%-258K
-131.63%-227K
1.60%-431K
31.84%-122K
Non-operating interest income
0.00%3K
0.00%3K
0.00%3K
0.00%13K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
-45.83%13K
103.75%3K
Non-operating interest expense
-14.10%262K
-0.38%260K
17.83%271K
139.86%1.07M
116.00%270K
199.02%305K
125.00%261K
127.72%230K
-3.90%444K
26.26%125K
Other net income (expense)
-104.73%-268K
-12.94M
-39,115.38%-20.29M
-25.96M
5.67M
101.29%52K
0
Gain on sale of security
-104.73%-268K
----
----
----
----
--5.67M
----
----
----
----
Special income (charges)
----
----
----
---25.36M
----
----
----
----
--0
----
-Less:Impairment of capital assets
----
----
----
--25.36M
----
----
----
----
--0
----
Other non- operating income (expenses)
----
---12.94M
----
9,646.15%5.07M
----
----
----
----
-21.21%52K
--0
Income before tax
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-461.31%-24.74M
-2,049.09%-27.1M
460.32%4.24M
21.14%-884K
-17.55%-998K
44.05%-4.41M
75.96%-1.26M
Income tax
0
0
0
33K
33K
0
0
0
0
0
Net income
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.32%4.24M
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
Net income continuous Operations
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.32%4.24M
21.14%-884K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
Minority interest income
16.67%-5K
-220.00%-6K
69.44%-11K
12.68%-62K
3.85%-25K
60.00%-6K
126.32%5K
81.25%-36K
65.20%-71K
-550.00%-26K
Net income attributable to the parent company
-134.61%-1.47M
-1,513.72%-14.35M
-31.70%-1.27M
-469.83%-24.71M
-2,094.98%-27.11M
465.49%4.25M
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-134.61%-1.47M
-1,513.72%-14.35M
-31.70%-1.27M
-469.83%-24.71M
-2,094.98%-27.11M
465.49%4.25M
19.33%-889K
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
Basic earnings per share
-132.43%-0.12
-1,426.13%-1.18
-31.47%-0.11
-3,185.71%-2.3
-2,255.39%-2.53
466.10%0.37
19.33%-0.0773
-46.45%-0.0837
88.59%-0.07
63.27%-0.1074
Diluted earnings per share
-300.00%-0.12
-1,426.13%-1.18
-31.47%-0.11
-3,185.71%-2.3
-2,255.39%-2.53
159.37%0.06
19.33%-0.0773
-46.45%-0.0837
88.59%-0.07
63.27%-0.1074
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 18K7K00000000
Operating revenue --18K--7K--0--0--0--0--0--0--0--0
Cost of revenue 1K11K00
Gross profit 17K-4K00
Operating expense -14.37%965K83.55%1.15M31.00%1.01M-15.67%3.4M-23.18%875K4.55%1.13M-37.90%626K-3.99%771K16.62%4.03M10.37%1.14M
Selling and administrative expenses -28.23%516K215.89%676K66.89%509K65.67%1.83M361.72%591K65.29%719K-53.28%214K-9.50%305K5.44%1.1M-37.25%128K
-Selling and marketing expense -99.57%2K-94.44%1K137.50%19K873.85%633K595.24%146K2,611.76%461K80.00%18K-52.94%8K-80.00%65K-46.15%21K
-General and administrative expense 99.22%514K244.39%675K64.98%490K15.11%1.2M315.89%445K-38.28%258K-56.25%196K-7.19%297K-0.76%1.04M-47.55%107K
Research and development costs -36.59%52K-38.02%75K-43.72%103K-83.50%278K-117.14%-108K-77.03%82K-54.51%121K2.23%183K37.44%1.69M20.69%630K
Depreciation amortization depletion 2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K
-Depreciation and amortization 2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K
Other operating expenses 142.22%109K816.67%110K3,733.33%115K43.70%171K11.88%113K650.00%45K200.00%12K-57.14%3K75.00%119K260.71%101K
Operating profit 15.88%-948K-84.19%-1.15M-31.00%-1.01M15.67%-3.4M23.18%-875K-4.55%-1.13M37.90%-626K3.99%-771K-18.33%-4.03M-10.37%-1.14M
Net non-operating interest income expense 14.24%-259K0.39%-257K-18.06%-268K-144.08%-1.05M-118.85%-267K-205.05%-302K-128.32%-258K-131.63%-227K1.60%-431K31.84%-122K
Non-operating interest income 0.00%3K0.00%3K0.00%3K0.00%13K0.00%3K0.00%3K0.00%3K0.00%3K-45.83%13K103.75%3K
Non-operating interest expense -14.10%262K-0.38%260K17.83%271K139.86%1.07M116.00%270K199.02%305K125.00%261K127.72%230K-3.90%444K26.26%125K
Other net income (expense) -104.73%-268K-12.94M-39,115.38%-20.29M-25.96M5.67M101.29%52K0
Gain on sale of security -104.73%-268K------------------5.67M----------------
Special income (charges) ---------------25.36M------------------0----
-Less:Impairment of capital assets --------------25.36M------------------0----
Other non- operating income (expenses) -------12.94M----9,646.15%5.07M-----------------21.21%52K--0
Income before tax -134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-461.31%-24.74M-2,049.09%-27.1M460.32%4.24M21.14%-884K-17.55%-998K44.05%-4.41M75.96%-1.26M
Income tax 00033K33K00000
Net income -134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.32%4.24M21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M
Net income continuous Operations -134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.32%4.24M21.14%-884K-17.55%-998K39.26%-4.41M62.54%-1.26M
Minority interest income 16.67%-5K-220.00%-6K69.44%-11K12.68%-62K3.85%-25K60.00%-6K126.32%5K81.25%-36K65.20%-71K-550.00%-26K
Net income attributable to the parent company -134.61%-1.47M-1,513.72%-14.35M-31.70%-1.27M-469.83%-24.71M-2,094.98%-27.11M465.49%4.25M19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -134.61%-1.47M-1,513.72%-14.35M-31.70%-1.27M-469.83%-24.71M-2,094.98%-27.11M465.49%4.25M19.33%-889K-46.42%-962K38.51%-4.34M63.27%-1.24M
Basic earnings per share -132.43%-0.12-1,426.13%-1.18-31.47%-0.11-3,185.71%-2.3-2,255.39%-2.53466.10%0.3719.33%-0.0773-46.45%-0.083788.59%-0.0763.27%-0.1074
Diluted earnings per share -300.00%-0.12-1,426.13%-1.18-31.47%-0.11-3,185.71%-2.3-2,255.39%-2.53159.37%0.0619.33%-0.0773-46.45%-0.083788.59%-0.0763.27%-0.1074
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -